EastWest Bioscience announced that company has completed the first production run of its CBD Pet Treats for the US Market. The premium CBD used in these CBD pet treats was supplied and produced through its joint venture partnership with Azema Sciences at its facility in Lebanon, Kentucky, USA. These CBD Pet Treats are value added products, leveraging the existing unique formula currently being sold throughout the Canadian Market and adding them with premium full spectrum CBD produced from its Lebanon, Kentucky Facility. Initially, the +CBD Chill Dog and +CBD Quick Cat will be sold through the company's Kentucky based distribution arm, EastWest Science USA and it is set to be shipped out late November 2019. EastWest's product development and sales strategy for the CBD pet treats in the USA will mirror the Company's Canadian sales strategy: gain brand awareness and establish distribution relationships for broad product distribution. As it establishes relationships with various distributors to sell the Company's unique and innovative hemp-based products, the Company is readying to expand each product to +CBD. The company's US Sales Team continues to fill its sales funnel in the USA. The products have been received very favorably by large independent retail chains in the US that wants to ensure that its vendors are in total control of the source material used in the products all the way to the shelf.